Current Report Filing (8-k)
February 24 2017 - 11:14AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 22, 2017
MICROBOT MEDICAL INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-19871
|
|
94-3078125
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
175 Derby Street, 27/1
Hingham, MA 02043
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (908) 938-5561
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On February 22, 2017, the Company issued a press release announcing that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a key technology patent covering a device for the prevention of shunt stenosis. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 9.01
|
Financial Statements and Exhibits
|
|
|
|
|
|
|
Exhibit
|
|
Description
|
|
|
|
|
|
|
99.1
|
|
Press Release dated February 22, 2017
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
MICROBOT MEDICAL INC.
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
|
Harel Gadot
Chairman, President, and Chief Executive Officer
|
|
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Mar 2023 to Mar 2024